Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

PMMI and ISPE Partner to Launch Pharma EXPO

Published: Monday, May 13, 2013
Last Updated: Monday, May 13, 2013
Bookmark and Share
New pharmaceutical processing and packaging event to co-locate with PACK EXPO International 2014.

PMMI and the International Society for Pharmaceutical Engineering (ISPE) have announced the debut of Pharma EXPO, a new event designed to connect pharmaceutical, medical device and nutraceutical manufacturers with the packaging, processing and other supply chain technologies they need to meet rigorous industry regulations and grow business.

The event will debut in 2014 and co-locate with PACK EXPO International (November 2-5, 2014; McCormick Place, Chicago).

The vision for Pharma EXPO is to be the world’s leading event for the pharmaceutical and medical industries. In addition to the exhibits portion of the event, which is designed to meet the needs of the manufacturers and suppliers, ISPE will produce a world-class conference program, scheduled to take place during the show.

Attendees will have an opportunity to see cutting-edge technology in packaging and processing and attend conference programs that address common challenges in the pharmaceutical lifecycle.

“Pharma EXPO is part of our strategy to make it more efficient for attendees to find the technologies they need,” says Charles D. Yuska, president and CEO of PMMI.

Yuska continued, “By partnering with ISPE, which is over 20,000 members strong, with a very robust knowledge and learning program, we can combine the best aspects of PACK EXPO with deep industry knowledge and insight to deliver a first-class event for the industry.”

“At our core, ISPE is about preparing our members to lead global change and innovation in pharmaceutical manufacturing sciences and technology,” says Nancy Berg, president and CEO of ISPE. “This venture event will provide a new vehicle to achieve that goal and provide members with a unique opportunity to be inspired by ideas and technologies developed for other industries.”

PACK EXPO has always had a strong presence in pharmaceutical and medical device manufacturing. Historically, upwards of 18 percent of end-users who attend PACK EXPO have identified themselves as pharmaceutical and medical device manufacturers, while one-third of all the exhibitors at PACK EXPO are suppliers to the pharmaceutical industry.

The partnership of ISPE, the world leader in pharmaceutical engineering and manufacturing, and PMMI, the world leader in packaging and processing, will make Pharma EXPO a leading pharmaceutical industry event.

The show will offer the attendees what they want most - exposure to the latest technologies, the opportunity to attend a full range of education sessions, as well as networking with industry professionals.

The co-located PACK EXPO International and Pharma EXPO are expected to attract 48,000 attendees, 2,000 exhibiting companies and over 1.1 million net square feet of exhibit space in 2014. Additional information about the new show will be released in the coming months.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Find Smart Solutions for Lifecycle Innovation at Pharma EXPO Debut
Co-located with PACK EXPO International, the debut edition of Pharma EXPO will bring over 200 exhibitors and 10,000 attendees together.
Saturday, March 22, 2014
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
NIH Study Determines Key Differences between Allergic and Non-Allergic Dust Mite Proteins
Researchers at NIH have uncovered factors that lead to the development of dust mite allergy and assist in the design of better allergy therapies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos